Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary

Archives of Osteoporosis - Tập 7 - Trang 3-20 - 2012
Hajime Orimo1, Toshitaka Nakamura2, Takayuki Hosoi3, Masayuki Iki4, Kazuhiro Uenishi5, Naoto Endo6, Hiroaki Ohta7, Masataka Shiraki8, Toshitsugu Sugimoto9, Takao Suzuki10, Satoshi Soen11, Yoshiki Nishizawa12, Hiroshi Hagino13, Masao Fukunaga14, Saeko Fujiwara15
1Japan Osteoporosis Foundation, Tokyo, Japan
2Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
3Department of Clinical Research and Development, National Center for Geriatrics and Gerontology, Obu City, Japan
4Department of Public Health, Kinki University Faculty of Medicine, Osakasayama, Japan
5Laboratory of Physiological Nutrition, Kagawa Nutrition University, Sakato, Japan
6Division of Orthopedic Surgery, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
7Clinical Medical Research Center, Women’s Medical Center of Sanno Medical Center, Tokyo, Japan
8Research Institute and Practice for Involutional Diseases, Azumino, Japan
9Internal Medicine I, Shimane University Faculty of Medicine, Shimane, Japan
10Research Institute, National Center for Geriatrics and Gerontology, Obu, Japan
11Department of Orthopaedic Surgery and Rheumatology, Nara Hospital, Kinki University School of Medicine, Ikoma, Japan
12Osaka City University, Osaka, Japan
13School of Health Science, Tottori University Faculty of Medicine, Yonago, Japan
14Kawasaki Medical School, Kurashiki, Japan
15Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan

Tóm tắt

In 1998, the first Japanese practice guidelines on osteoporosis was published. It has been updated several times, with the most recent being the full-scale 2011 edition and its abridged edition. The present guidelines provide information for the managements of primary osteoporosis in postmenopausal women and men over 50 years old, a summary of the evidence for the treatment of secondary osteoporosis, and a summary of the evidence for the prevention of osteoporosis in younger people. The present Executive Summary is primarily based on the content of the 2011 Japanese abridged edition. One of the key changes is revision of the criteria for initiation of pharmacological treatment, along with an introduction of the fracture risk factors used in FRAX®. Key figures and tables were selected from the Japanese abridged edition and a reference list was added. The essential points of the Japanese practice guidelines on osteoporosis were translated into English for the first time. It is hoped that the content of the guidelines becomes known throughout the world.

Tài liệu tham khảo

Yoshimura N, Muraki S, Oka H et al (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628 Orimo H, Yaegashi Y, Onoda T et al (2009) Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends. Arch Osteoporos 4:71–77 Yoshimura N, Kinoshita H, Oka H et al (2006) Cumulative incidence and changes in prevalence of vertebral fractures in a rural Japanese community: a 10-year follow-up of the Miyama cohort. Arch Osteoporos. doi:10.1007/s11657-006-0007-0 Orimo H, Hayashi Y, Fukunaga M et al (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337 You K (2011) Osteoporos Jpn 19:626, in Japanese Nishizawa Y, Ohta h, Miura M, et al. Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 Edition). J Bone Miner Metab. doi:10.1007/s00774-012-0392-y Orito S, Kuroda T, Onoe Y et al (2009) Age-related distribution of bone and skeletal parameters in 1322 Japanese young women. J Bone Miner Metab 27:698–704 Orimo H, Hosoi T, Fukunaga M (eds) (2009) Manual for osteoporosis screening and health guidance. Life Science Publishing, Tokyo, in Japanese MacLean C, Newberry S, Maglione M et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148:197–213 Papadimitropoulos E, Wells G, Shea B et al (2002) Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560–569 Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999–2006 Matsumoto T, Ito M, Hayashi Y et al (2011) A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures: a randomized, active comparator, double-blind study. Bone 49:605–612 Cockayne S, Adamson J, Lanham-New S et al (2009) Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166:1256–1261 Hagino H, Nishizawa Y, Sone T et al (2009) A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone 44:1078–1084 Matsumoto T, Hagino H, Shiraki M et al (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20:1429–1437 Orimo H, Morii H, Inoue T et al (1996) Effect of elcatonin on involutional osteoporosis. J Bone Miner Metab 14:73–78 Nakano T (2011) Clinical effect of calcitonin (elcatonin) on acute pain for osteoporotic vertebral fracture: semi blind randomized controlled trial. Osteoporos Jpn 19:279 Orimo H, Nakamura T, Fukunaga M et al (2011) Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT)–02. Curr Med Res Opin 27:1273–1284
Thông tin
Thông tin xuất bản

Archives of Osteoporosis

Tập 7

3-20

Thông tin tác giả